CUFinder

Simone Lubrano

About Simone Lubrano

Simone Lubrano, With an exceptional h-index of 7 and a recent h-index of 6 (since 2020), a distinguished researcher at University of California, San Diego, specializes in the field of Cancer Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

A novel combination therapy targeting RAF, MEK and FAK to overcome skin cutaneous melanoma treatment resistance

High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma

Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ–focal adhesion kinase signaling circuitry

Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC)

Correction: Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma

Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma

Abstract A20: Gαq controls the Hippo pathway through MOB1 tyrosine phosphorylation by FAK

Simone Lubrano Information

University

Position

Moores Cancer Center

Citations(all)

396

Citations(since 2020)

369

Cited By

168

hIndex(all)

7

hIndex(since 2020)

6

i10Index(all)

7

i10Index(since 2020)

6

Email

University Profile Page

Google Scholar

Simone Lubrano Skills & Research Interests

Cancer Biology

Top articles of Simone Lubrano

A novel combination therapy targeting RAF, MEK and FAK to overcome skin cutaneous melanoma treatment resistance

Cancer Research

2024/3/22

Simone Lubrano
Simone Lubrano

H-Index: 4

Farhoud Faraji
Farhoud Faraji

H-Index: 20

Nadia Arang
Nadia Arang

H-Index: 9

Ruth Halaban
Ruth Halaban

H-Index: 34

Andrew Aplin
Andrew Aplin

H-Index: 32

High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma

Cell Reports Medicine

2023/11/21

Nadia Arang
Nadia Arang

H-Index: 9

Simone Lubrano
Simone Lubrano

H-Index: 4

Robert Saddawi-Konefka
Robert Saddawi-Konefka

H-Index: 8

Farhoud Faraji
Farhoud Faraji

H-Index: 20

Daehwan Kim
Daehwan Kim

H-Index: 5

Yuan Zhou
Yuan Zhou

H-Index: 16

Zhiyong Wang
Zhiyong Wang

H-Index: 9

Danielle L Swaney
Danielle L Swaney

H-Index: 26

Jing Yang
Jing Yang

H-Index: 14

Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ–focal adhesion kinase signaling circuitry

Journal of Biological Chemistry

2023/2/1

Nadia Arang
Nadia Arang

H-Index: 9

Simone Lubrano
Simone Lubrano

H-Index: 4

Damiano Cosimo Rigiracciolo
Damiano Cosimo Rigiracciolo

H-Index: 15

Daniela Nachmanson
Daniela Nachmanson

H-Index: 4

Prashant Mali
Prashant Mali

H-Index: 34

Olivier Harismendy
Olivier Harismendy

H-Index: 28

Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC)

Journal of Experimental & Clinical Cancer Research

2022/6/3

Damiano Cosimo Rigiracciolo
Damiano Cosimo Rigiracciolo

H-Index: 15

Rosamaria Lappano
Rosamaria Lappano

H-Index: 29

Nadia Arang
Nadia Arang

H-Index: 9

Simone Lubrano
Simone Lubrano

H-Index: 4

Ernestina Marianna De Francesco
Ernestina Marianna De Francesco

H-Index: 23

Antonino Belfiore
Antonino Belfiore

H-Index: 41

Marcello Maggiolini
Marcello Maggiolini

H-Index: 45

Correction: Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma

Clinical Cancer Research

2021/8/15

Robert Saddawi-Konefka
Robert Saddawi-Konefka

H-Index: 8

Simone Lubrano
Simone Lubrano

H-Index: 4

Nadia Arang
Nadia Arang

H-Index: 9

Xingyu Wu
Xingyu Wu

H-Index: 7

Kyle Ford
Kyle Ford

H-Index: 3

Prashant Mali
Prashant Mali

H-Index: 34

Takami Sato
Takami Sato

H-Index: 2

Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma

Clinical Cancer Research

2021/6/1

Robert Saddawi-Konefka
Robert Saddawi-Konefka

H-Index: 8

Simone Lubrano
Simone Lubrano

H-Index: 4

Nadia Arang
Nadia Arang

H-Index: 9

Xingyu Wu
Xingyu Wu

H-Index: 7

Kyle Ford
Kyle Ford

H-Index: 3

Prashant Mali
Prashant Mali

H-Index: 34

Takami Sato
Takami Sato

H-Index: 2

Abstract A20: Gαq controls the Hippo pathway through MOB1 tyrosine phosphorylation by FAK

Molecular Cancer Research

2020/8/1

Xiaodong Feng
Xiaodong Feng

H-Index: 8

Nadia Arang
Nadia Arang

H-Index: 9

Damiano Cosimo Rigiracciolo
Damiano Cosimo Rigiracciolo

H-Index: 15

Zhiyong Wang
Zhiyong Wang

H-Index: 9

Simone Lubrano
Simone Lubrano

H-Index: 4

Marcello Maggiolini
Marcello Maggiolini

H-Index: 45

Pablo Tamayo
Pablo Tamayo

H-Index: 59

See List of Professors in Simone Lubrano University(University of California, San Diego)